Severe cardiac AL amyloidosis in an elderly patient with multiple SARS-CoV-2 reinfection: a case report
EV Reznik, TL Nguyen, OA Ettinger… - Russian Journal of …, 2023 - russjcardiol.elpub.ru
Introduction. The relationship between systemic amyloidosis and coronavirus disease 2019
(COVID-19) has not been sufficiently studied to date. This paper presents a case of the …
(COVID-19) has not been sufficiently studied to date. This paper presents a case of the …
[HTML][HTML] Morbimortalidad de las enfermedades cardiovasculares: causas, pruebas diagnósticas y prevención.
MM Guerrero-Toala, AN Villavicencio-Intriago… - …, 2023 - investigarmqr.com
Las enfermedades cardiovasculares representan una causa importante de morbimortalidad
en la población mundial. La incidencia y prevalencia de estas patologías han aumentado …
en la población mundial. La incidencia y prevalencia de estas patologías han aumentado …
Heartbeat: hospitalisation for COVID-19 is associated with an increased risk of subsequent adverse cardiovascular events
CM Otto - 2023 - heart.bmj.com
In order to assess whether previous COVID-19 infection might be associated with a higher
risk of subsequent adverse cardiovascular disease (CVD) events, Raisi-Estabragh and …
risk of subsequent adverse cardiovascular disease (CVD) events, Raisi-Estabragh and …
Correspondence on 'Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank'by Raisi-Estabragh et al
O Jolobe - Heart, 2023 - heart.bmj.com
To the Editor No evaluation of cardiovascular disease and mortality sequelae of COVID-19 1
would be complete without documentation of the increase in the prevalence of mechanical …
would be complete without documentation of the increase in the prevalence of mechanical …
[HTML][HTML] Increased Cardiovascular Mortality in Ecuador during COVID-19 Pandemic
M Fornasini, I Sisa, ME Baldeon - Annals of Global Health, 2023 - annalsofglobalhealth.org
Before the COVID-19 pandemic, chronic noncommunicable diseases (NCDs), represented a
high burden for low and middle-income countries. Patients with NCDs are at higher risk of …
high burden for low and middle-income countries. Patients with NCDs are at higher risk of …
Острое повреждение миокарда у пациентов с COVID-19: патогенетические аспекты, вопросы дифференциальной диагностики
АА Плешко, ЕБ Петрова, ЕА Григоренко, ТВ Горбат… - 2023 - rep.bsmu.by
В свете пандемии COVID-19, вызванной вирусом SARS-CoV-2, сердечно-сосудистые
осложнения становятся медико-социальной проблемой, значимость которой в …
осложнения становятся медико-социальной проблемой, значимость которой в …
Las alteraciones metabólicas y funcionales asociadas a la COVID-19
Á Aparisi Sanz - 2023 - uvadoc.uva.es
La enfermedad por coronavirus 2019 (COVID-19) es causada por el virus del síndrome
respiratorio agudo grave 2 (SARS-CoV-2) y ha sido declarada como una pandemia por la …
respiratorio agudo grave 2 (SARS-CoV-2) y ha sido declarada como una pandemia por la …
Association between COVID-19 and incidence of CVD and all-cause mortality among patients with diabetes
HS Jung, JW Choi - 2023 - researchsquare.com
Background Although the risk of coronavirus disease 2019 (COVID-19) infection is higher in
patients who are diagnosed with diabetes than in those who are not, research on the risk of …
patients who are diagnosed with diabetes than in those who are not, research on the risk of …
Evidence of Autoinflammation as the Principal Mechanism of Myocardial Injury in SARS-CoV-2 PCR-Positive Autopsy Hearts
ME Hammond, ED Christensen, M Belenky, GL Snow… - 2023 - researchsquare.com
Background Disease from Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-
2) remains the third leading cause of death in the United States, after cancer and heart …
2) remains the third leading cause of death in the United States, after cancer and heart …